Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04263337 · ClinicalTrials.gov registry record · Phase 1
NFL LONG Prospective Study
A Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
- Active
- Registry status
- Phase 1
- Development phase
- 250
- Enrollment target
NCT04263337 is a Phase 1 study that is active but no longer recruiting, run by University of North Carolina, Chapel Hill. The registered enrollment target is 250 participants.
The verdict
NCT04263337, a Phase 1 study, is active but no longer recruiting, sponsored by University of North Carolina, Chapel Hill.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 250 participants
- Enrollment target
Study Summary
The purpose of this 5-year prospective research study is to characterize the association between concussions, sub-concussive exposure, and long-term neurologic health outcomes in former NFL players. To achieve the study aims, the investigators will conduct detailed research visits that include clinical outcome assessments, blood-based biomarkers, advanced magnetic resonance imaging (MRI), positron emission tomography (PET) using investigational tracers and genetic testing. Ultimately, the goal of this study is to translate the findings from this study into clinical, interventional studies for at risk former NFL players.
Interventions
- DRUG [11C] PiB
- DRUG [18F] PBR111
- DRUG [18F] Flortaucipir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2020-03-12 |
| Est. Completion | 2028-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04263337
The ClinicalTrials.gov registry entry for NCT04263337 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which [11C] PiB is the first listed.
NCT04263337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04263337 about?
NCT04263337 is a clinical study titled "NFL LONG Prospective Study". The purpose of this 5-year prospective research study is to characterize the association between concussions, sub-concussive exposure, and long-term neurologic health outcomes in former NFL players. To achieve the study aims, the investigators will conduct detailed research visits that include clini...
What is the current status of trial NCT04263337?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 250 participants. The study started on 2020-03-12. Estimated completion is 2028-08.
What interventions are being tested in trial NCT04263337?
The interventions under investigation include: [11C] PiB (DRUG), [18F] PBR111 (DRUG), [18F] Flortaucipir (DRUG).
Who is sponsoring clinical trial NCT04263337?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.